Seer (SEER) Net Margin (2020 - 2026)

Seer (SEER) recorded quarterly Net Margin of 602.83% in Q1 2026, down 58.34% quarter-over-quarter from 380.72% in Q4 2025, and down 12844.0% on a YoY basis from N/an in Q1 2025.

Seer (SEER) Net Margin (2020 - 2026) Analysis & Trends

Seer's Net Margin history runs 7 years deep, the most recent figure standing at 602.83% for Q1 2026.

  • In Q1 2026, Net Margin fell 12844.0% year-over-year to 602.83%; the TTM figure through Mar 2026 stood at 464.78% (up 9774.0% YoY), while the FY2025 annual figure was 443.96%, up 16893.0% from the prior year.
  • Net Margin was 602.83% for Q1 2026 at Seer, down from 380.72% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 1521.99% in Q4 2023 to a low of 743.82% in Q2 2024.
  • Historically, Net Margin has averaged 439.81% across 5 years, with a median of 549.75% in 2024.
  • The sharpest annual moves came in 2022 and 2024: Net Margin jumped 2578444 bps in 2022, then plunged 207174 bps in 2024.
  • A 5-year view of Net Margin shows it stood at 489.14% in 2022, then surged by 411 bps to 1521.99% in 2023, then plunged by 136 bps to 549.75% in 2024, then surged by 31 bps to 380.72% in 2025, then slumped by 58 bps to 602.83% in 2026.
  • The last three Net Margin figures came in at 602.83% (Q1 2026), 380.72% (Q4 2025), and 442.47% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - -
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - -
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn 0.82%
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - -
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - -
7 Psyence Biomedical 251.43 Bn 251.42 Bn - -
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn 34.53%
9 Abivax 94.37 Bn 94.37 Bn - -
10 Seer 99.67 Mn 99.67 Mn 982,000.00 -602.83%

Historic Data

Download Data
DateValue
Mar 31, 2026 -602.83%
Dec 31, 2025 -380.72%
Sep 30, 2025 -442.47%
Jun 30, 2025 -479.49%
Mar 31, 2025 -474.39%
Dec 31, 2024 -549.75%
Sep 30, 2024 -528.97%
Jun 30, 2024 -743.82%
Mar 31, 2024 -674.46%
Dec 31, 2023 1,521.99%
Sep 30, 2023 -506.68%
Jun 30, 2023 -584.61%
Mar 31, 2023 -591.14%
Dec 31, 2022 -489.14%
Sep 30, 2022 -606.32%
Jun 30, 2022 -630.07%
Mar 31, 2022 -713.95%
Dec 31, 2021 -643.80%
Sep 30, 2021 -853.13%
Jun 30, 2021 -1,245.58%